Who Paid My Doc
Joseph Miranda
Dentist, Dental Public Health Whippany, NJ Doctor of Dentistry
NPI 1477021202 CMS profile 5697261
279 Whippany Rd, Whippany, NJ 07981
General payments
$124
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Joseph Miranda of Whippany, NJ is reported in the CMS Open Payments database as having received $124 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 49th percentile of Dentist, Dental Public Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $113 | 1 | |
| 2019 | General | $11 | 1 |
Beside peers
- Joseph Miranda
- Dentist, Dental Public Health median
- Middle half of Dentist, Dental Public Health
- National median
In program year 2025, general payments to Joseph Miranda were reported at $0. Among 211 Dentist, Dental Public Health profiles paid that year, the median was $71 and the middle half received between $25 and $180.
Show as a table
| Year | Joseph Miranda | Dentist, Dental Public Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $11 | $55 | $23–$140 | $163 |
| 2020 | $0 | $60 | $20–$127 | $114 |
| 2021 | $0 | $72 | $28–$162 | $132 |
| 2022 | $113 | $52 | $19–$180 | $149 |
| 2023 | $0 | $52 | $20–$146 | $160 |
| 2024 | $0 | $67 | $25–$186 | $164 |
| 2025 | $0 | $71 | $25–$180 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 3 drugsPart D claims
65
Drug cost
$262
Branded share of claims
16.9%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Amoxicillin | Generic | 41 | $137 | |
| Clindamycin Hcl | Generic | 13 | $63 | |
| Sodium Fluoride Fluoride (Sodium) | Brand | 11 | $62 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Dental Public Health in New Jersey
Ismari Labrada
Dentist, Dental Public Health · Union City, NJ
Daryoush Haghighi
Dentist, Dental Public Health · Montclair, NJ
Joseph Dalbon
Dentist, Dental Public Health · West Caldwell, NJ
Lussi Ronquillo Aguilar
Dentist, Dental Public Health · Union, NJ
Brianna D'elia
Dentist, Dental Public Health · Florham Park, NJ
Robert Logan
Dentist, Dental Public Health · Kinnelon, NJ
Related records
Dentist, Dental Public Health in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Dental Public Health
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.